Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-05
2005-07-05
Fay, Zohreh (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S412000, C514S912000
Reexamination Certificate
active
06914070
ABSTRACT:
This invention relates to the use of potent potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.
REFERENCES:
patent: 4386098 (1983-05-01), Woltersdorf, Jr. et al.
patent: 4416890 (1983-11-01), Woltersdorf, Jr.
patent: 4426388 (1984-01-01), Woltersdorf, Jr.
patent: 4599353 (1986-07-01), Bito
patent: 4668697 (1987-05-01), Shepard et al.
patent: 4797413 (1989-01-01), Baldwin et al.
patent: 4824857 (1989-04-01), Goh et al.
patent: 4863922 (1989-09-01), Baldwin et al.
patent: 4883819 (1989-11-01), Bito
patent: 5001153 (1991-03-01), Ueno et al.
patent: 5153192 (1992-10-01), Dean et al.
patent: 5240923 (1993-08-01), Dean et al.
patent: 5378703 (1995-01-01), Dean et al.
patent: 5573758 (1996-11-01), Adorante et al.
patent: 5925342 (1999-07-01), Adorante et al.
patent: WO 89/10757 (1989-11-01), None
patent: WO 94/28900 (1994-12-01), None
patent: WO 96/33719 (1996-10-01), None
Invest. Ophthalmol. Vis. Sci., 38, 1997.
Arch. Ophthalmol., vol. 112, Jan. 1994, pp. 37-44.
Invest. Ophthalmol. & Vis. Sci., 32, 5, Apr. 1991, pp. 1593-1599.
P. Martin-Vasallo, et al., J Cell. Physiol., vol. 141, No. 2, 1989, pp. 243-252.
Garcia Maria L.
Kaczorowski Gregory J.
McManus Owen B.
Ayler Sylvia A.
Camara Valerie J.
Fay Zohreh
Merck & Co. , Inc.
LandOfFree
Ophthalmic compositions for treating ocular hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic compositions for treating ocular hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic compositions for treating ocular hypertension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3419272